Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Biologicals : Journal of the International Association of Biological Standardization|May 14, 2018
Adherence to biologic therapy - Does it vary with ethnicity?Muhammad K Nisar, Waqas Mirza, Aneesa Rafiq, et al.
Clinical Rheumatology|November 27, 2012
Same-day or historical ESR for disease activity score measurement: does it matter?Sven Brode, Muhammad K Nisar, Andrew J K Ostör
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|April 10, 2025
Rheumatic conditions associated with interstitial lung diseases: real-world outcomes in a secondary care settingAlex Francioni, Muhammad K Nisar, Natasha Ramsundar, et al.
Clinical Rheumatology|January 9, 2013
What do we know about juvenile idiopathic arthritis and vitamin D? A systematic literature review and meta-analysis of current evidenceMuhammad K Nisar, Falak Masood, Paul Cookson, et al.
Clinical and Experimental Rheumatology|October 10, 2012
Does methotrexate increase the risk of varicella or herpes zoster infection in patients with rheumatoid arthritis? A systematic literature reviewNatalie Zhang, Sarah Wilkinson, Mehmood Riaz, et al.
Rheumatology (Oxford, England)|December 14, 2011
Non-infectious pulmonary toxicity of rituximab: a systematic reviewAndreas V Hadjinicolaou, Muhammad K Nisar, Helen Parfrey, et al.
BMC Medicine|February 14, 2023
Approaches to optimising access to NICE-approved biologic anti-TNFs for patients with rheumatoid arthritis with moderately active diseasePeter C Taylor, Ayman Askari, Ernest Choy, et al.
Clinical Rheumatology|June 19, 2026
The effect of biologic disease modifying anti-rheumatic drugs on the neutrophil-lymphocyte ratio in psoriatic arthritis patientsMartin Lauran, Chelsea Kyeremateng, Afrida Haque, et al.
BJC Reports|November 8, 2024
Aromatase inhibitors and fracture prevention - do 2017 guidelines work in real world?Anem Mirza, Zeyar Win Naing, Parisa Khonsari, et al.
Rheumatology (Oxford, England)|October 25, 2011
Non-infectious pulmonary complications of newer biological agents for rheumatic diseases--a systematic literature reviewAndreas V Hadjinicolaou, Muhammad K Nisar, Shweta Bhagat, et al.
Pageof 3